A Neuropeptide Y Variant (rs16139) Associated with Major Depressive Disorder in Replicate Samples from Chinese Han Population

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Wang, Yongjun ^a,c   Yang, Yutao ^b   Hui, Li ^b   Tie, Changle ^b   Li, Feng ^b   Xu, Zhi Qing David ^b   Wang, Chuanyue ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c TIANJIN ANDING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LIGASE; NEUROPEPTIDE Y;

ADULT; ARTICLE; CHINESE; CHINESE HAN; CONTROLLED STUDY; DNA ISOLATION; DSM-IV; ENZYME ASSAY; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NEUROPEPTIDE Y; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84874545815     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057042     Document Type: Article

References (26)

1. Andrews G, Poulton R, Skoog I, (2005) Lifetime risk of depression: restricted to a minority or waiting for most? Br J Psychiatry 187: 495-6.
2. Barlow DH (2005) Abnormal psychology: An integrative approach 248-49p.
3. Rhee SH, Waldman ID, (2002) Genetic and environmental influences on antisocial behavior: a meta-analysis of twin and adoption studies, Psychol Bull. 128(3): 490-529.
4. Kendler KS, Prescott CA, (1999) A population-based twin study of lifetime major depression in men and women, Arch Gen Psychiatry. 56(1): 39.
5. Mickey BJ, Zhou Z, Heitzeg MM, Heinz E, Hodgkinson CA, et al. (2011) Emotion processing, major depression, and functional genetic variation of neuropeptide Y. Arch Gen Psychiatry. 68(2): 158-66.
6. Heilig M, (2004) The NPY system in stress, anxiety and depression. Neuropeptides 38(4): 213-24.
7. Domschke K, Dannlowski U, Hohoff C, Ohrmann P, Bauer J, et al. (2010) Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression. Eur Neuropsychopharmacol 20(5): 301-9.
8. Lohoff FW, (2010) Overview of the genetics of major depressive disorder. Curr Psychiatry Rep 12(6): 539-46.
9. Weizman S, Gonda X, Dome P, Faludi G, (2012) Pharmacogenetics of antidepressive drugs: a way towards personalized treatment of major depressive disorder. Neuropsychopharmacol Hung 14(2): 87-101.
10. Morales-Medina JC, Dumont Y, Quirion R, (2010) A possible role of neuropeptide Y in depression and stress. Brain Res 1314: 194-205.
11. Heilig M, Zachrisson O, Thorsell A, Ehnvall A, Mottagui-Tabar S, et al. (2004) Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J Psychiatr Res 38(2): 113-21.
12. Madaan V, Wilson DR, (2009) Neuropeptides: relevance in treatment of depression and anxiety disorders. Drug News Perspect 22(6): 319-24.
13. Mickey BJ, Zhou Z, Heitzeg MM, Heinz E, Hodgkinson CA, et al. (2011) Emotion processing, major depression, and functional genetic variation of neuropeptide Y. Arch Gen Psychiatry. 68(2): 158-66.
14. Thorsell A, Svensson P, Wiklund L, Sommer W, Ekman R, et al. (1998) Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress. Regul Pept. 75-76: 247-54.
15. Thorsell A, Michalkiewicz M, Dumont Y, Quirion R, Caberlotto L, et al. (2000) Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci U S A 97(23): 12852-7.
16. Karl T, Chesworth R, Duffy L, Herzog H, (2010) Acoustic startle response and sensorimotor gating in a genetic mouse model for the Y1 receptor. Neuropeptides. 44(3): 233-9.
17. Domschke K, Dannlowski U, Hohoff C, Ohrmann P, Bauer J, et al. (2010) Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression. Eur Neuropsychopharmacol 20(5): 301-9.
18. Witt SH, Buchmann AF, Blomeyer D, Nieratschker V, Treutlein J, et al. (2011) An interaction between a neuropeptide Y gene polymorphism and early adversity modulates endocrine stress responses. Psychoneuroendocrinology 36(7): 1010-20.
19. Southwick SM, Vythilingam M, Charney DS, (2005) The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu Rev Clin Psychol 1: 255-91.
20. Sommer WH, Lidström J, Sun H, Passer D, Eskay R, et al. (2010) Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect. Hum Mutat 31(8): E1594-608.
21. Moreno FA, Parkinson D, Palmer C, Castro WL, Misiaszek J, et al. (2010) CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls. Eur Neuropsychopharmacol 20(1): 18-24.
22. Cizza G, Marques AH, Eskandari F, Christie IC, Torvik S, et al. (2008) Elevated neuroimmune biomarkers in sweat patches and plasma of premenopausal women with major depressive disorder in remission: the POWER study. Biol Psychiatry 64(10): 907-11.
23. Hou C, Jia F, Liu Y, Li L, (2006) CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder. Brain Res 1095(1): 154-8.
24. Sjöholm LK, Melas PA, Forsell Y, Lavebratt C, (2009) PreproNPY Pro7 protects against depression despite exposure to environmental risk factors. J Affect Disord 118(1-3): 124-30.
25. Bosker FJ, Hartman CA, Nolte IM, Prins BP, Terpstra P, et al. (2011) Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry 16(5): 516-32.
26. Ding B, Bertilsson L, Wahlestedt C, (2002) The single nucleotide polymorphism T1128C in the signal peptide of neuropeptide Y (NPY) was not identified in a Korean population. J Clin Pharm Ther 27(3): 211-2.